Suppr超能文献

密歇根州底特律市 2020 年 7 月,疫苗有效性和安全性对 COVID-19 疫苗接种意愿的影响。

Effect of vaccine effectiveness and safety on COVID-19 vaccine acceptance in Detroit, Michigan, July 2020.

机构信息

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.

Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.

出版信息

Hum Vaccin Immunother. 2021 Sep 2;17(9):2940-2945. doi: 10.1080/21645515.2021.1917233. Epub 2021 May 17.

Abstract

This study examined whether future COVID-19 vaccine acceptance differed based on an experimental manipulation of the vaccine safety and effectiveness profile. Data come from the Detroit Metro Area Community Study, a population-based study conducted July 15-20, 2020. Participants were asked whether they would get a new COVID-19 vaccine after being randomly assigned information about the vaccine's effectiveness (50% or 95%) and chance of fever (5% or 20%). Among 1,117 Detroiters, 51.3% would accept a COVID-19 vaccine that is 50% effective and 77.1% would accept a vaccine that is 95% effective. Women and adults ≥65 were more accepting of a vaccine; Black Detroiters were less accepting. Believing vaccines to be important, effective, and safe was associated with higher acceptance. Uptake of a COVID-19 may be limited, depending on perceived vaccine effectiveness and general attitudes toward vaccines. Public health approaches to modifying these attitudes will be especially important in the Black community.

摘要

这项研究旨在探究在疫苗安全性和有效性的实验性操作下,人们对未来 COVID-19 疫苗的接受程度是否会有所不同。该研究的数据来自于底特律都会区社区研究,这是一项在 2020 年 7 月 15 日至 20 日进行的基于人群的研究。研究对象被随机分配有关疫苗有效性(50%或 95%)和发烧几率(5%或 20%)的信息后,被问及是否会接种新的 COVID-19 疫苗。在 1117 名底特律人中,有 51.3%的人会接受有效性为 50%的 COVID-19 疫苗,而 77.1%的人会接受有效性为 95%的疫苗。女性和 65 岁以上的成年人更愿意接种疫苗;而黑人底特律人则不太愿意。认为疫苗很重要、有效且安全与更高的接种意愿有关。COVID-19 的接种率可能会受到限制,这取决于人们对疫苗有效性的看法和对疫苗的总体态度。在黑人社区中,改变这些态度的公共卫生方法将尤为重要。

相似文献

引用本文的文献

4
Biases in COVID-19 vaccine effectiveness studies using cohort design.使用队列设计的COVID-19疫苗有效性研究中的偏倚。
Front Med (Lausanne). 2024 Oct 30;11:1474045. doi: 10.3389/fmed.2024.1474045. eCollection 2024.

本文引用的文献

1
The Johnson & Johnson Vaccine for COVID-19.强生公司的新冠疫苗。
JAMA. 2021 Apr 20;325(15):1575. doi: 10.1001/jama.2021.2927.
2
SARS-CoV-2 Vaccines.严重急性呼吸综合征冠状病毒2型疫苗
JAMA. 2021 Apr 6;325(13):1318-1320. doi: 10.1001/jama.2021.3199.
3
5
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
6
A global survey of potential acceptance of a COVID-19 vaccine.一项针对 COVID-19 疫苗潜在接受度的全球调查。
Nat Med. 2021 Feb;27(2):225-228. doi: 10.1038/s41591-020-1124-9. Epub 2020 Oct 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验